RARebeka Amin

Rebeka Amin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rebeka Amin has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Ulrich Hegerl

    Depression Research Centre of German Foundation for Depression and Suicide Prevention, Leipzig, Germany, 49 034122387420

    5 shared publications
  • Milica Petrovic

    Affiliation Research Center of the German Foundation for Depression and Suicide Prevention, Department of Psychiatry, Psychosomatics and Psychotherapy, University Clinic, Goethe University, Heinrich-Hoffmann-Str 10, Frankfurt, Germany

    4 shared publications
  • Hanna Reich

    Depression Research Centre of the German Depression Foundation, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital, Goethe University, Frankfurt am Main, Germany

    3 shared publications
  • Simon Schreynemackers

    Research Centre of the German Foundation for Depression and Suicide Prevention, Department for Psychiatry, Psychosomatics and Psychotherapy, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany

    3 shared publications
  • Hannah Oppenheimer

    Division of Mental Health and Substance Abuse, Diakonhjemmet Hospital, Oslo, Norway

    2 shared publications
  • Lisa Busshart

    Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Frankfurt, Research Center of German Foundation for Depression and Suicide Prevention, Heinrich-Hoffmann-Str. 10, Frankfurt am Main, 60528, Germany, 49 162 9464667

    2 shared publications

Latest Publications

  • Open Access

    Distinguishing Common Digital Phenotyping and Self-Report Parameters for Monitoring and Predicting Depression: Scoping Review

    by Lisa Busshart, Milica Petrovic, Rebeka Amin, Ulrich Hegerl

    Background: Digital health interventions incorporating self-management strategies are increasingly used to support individuals in managing depression. These interventions often leverage self-monitoring and passive sensor-based data collection to provide personalized feedback, guiding behavioral change. With the proliferation of smartphones and wearable devices, there is growing potential to continuously collect behavioral and physiological data. However, a major limitation in the field is the lack of consolidated evidence on which specific parameters are most useful for monitoring and predicting depression-related outcomes. Objective: This scoping review aims to identify and synthesize common digital phenotyping and self-report parameters for monitoring and predicting depression. Specifically, it addresses the methodological and knowledge gap concerning which types of sensor-based and self-reported data are most frequently used and which demonstrate predictive value in tracking changes in depressive symptoms across digital platforms. Methods: A literature search was conducted across 4 databases, including PubMed, Embase, Cochrane Library, and the Web of Science Core Collection. Articles published between January 1, 2021, and November 26, 2025, were included. Eligible studies included adults (≥18 years) with depression confirmed through validated clinical measures and using digital approaches that collected passive sensor data, self-reports, or both. Studies focusing on comorbid disorders, nondigital interventions, or not reporting depression-related outcomes were excluded. The PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines were followed, and a 5-stage methodological framework for scoping reviews was implemented. Quality assessment was performed using the Downs and Black Instrument and the Mixed Methods Appraisal Tool (MMAT). Results: Nineteen studies were included, comprising a total of 85,193 participants. Most studies used smartphone- or wearable-based tools, with passive sensing as the predominant data source and Patient Health Questionnaire-9 (PHQ-9) as the most commonly used depression measure. Five overarching parameter categories were identified: (1) physical activity and location, (2) behavioral patterns, (3) physiological signals, (4) sleep indicators, and (5) sociability and self-reported assessments. Within these categories, 11 metrics, including step count, heart rate variability, sleep duration and mood self-ratings, were most frequently reported. Most studies used a multimodal digital phenotyping approach, integrating passive sensor-derived data with active user-reported input, enabling more individualized symptom monitoring over time. Conclusions: This scoping review provides a novel synthesis of common digital parameters used across diverse tools for monitoring and predicting depression, moving beyond tool- or modality-specific perspectives adopted in prior reviews. Unlike existing reviews focusing on individual sensing modalities, prediction methods, or intervention effectiveness, this review maps shared parameters across observational, predictive, and interventional studies. By identifying convergent digital markers, the review supports comparability across studies and informs future model development. These findings have practical implications for the design of scalable digital mental health tools and for translating digital phenotyping into real-world clinical and self-management contexts.


  • Open Access

    Use of Mobile Sensing Data for Longitudinal Monitoring and Prediction of Depression Severity: Systematic Review

    by Rebeka Amin, Simon Schreynemackers, Hannah Oppenheimer, Milica Petrovic, Ulrich Hegerl, Hanna Reich

    Background: Depression is highly recurrent and heterogeneous. The unobtrusive, continuous collection of mobile sensing data via smartphones and wearable devices offers a promising approach to monitor and predict individual depression trajectories, distinguish illness states, and anticipate changes in symptom severity. Objective: This systematic review evaluates whether objective data from wearable devices and smartphones can (1) monitor and distinguish different states of depression, (2) predict changes in symptom severity, and (3) identify clinically relevant objective features for tracking and forecasting depression within diagnosed individuals. Methods: We searched PubMed and Web of Science databases for English-language studies (published 2012-2022) that used smartphone or wearable device data, included participants aged ≥14 years with a depression diagnosis, and collected continuous data for at least 12 weeks. Results: Out of 12,997 peer-reviewed articles, 9 original studies met the inclusion criteria, with sample sizes ranging from 45 to 2200 and durations of 12-52 weeks. Of the 9 studies, 3 used smartphone data, 1 used wearable device data, and 5 used both data types. Commonly collected variables were step count, distance moved, smartphone usage, call logs, sleep, heart rate, light exposure, and speech patterns. One study (11%) successfully differentiated between depressive states (worsening, relapse, or recovery). Six studies (67%) showed that mobile sensing data could predict depressive episodes or symptom severity. Four studies reported the predictive accuracy for depression using mobile sensing data from smartphones and wearable devices, ranging from 81% to 91%. Higher accuracy was achieved with personalized models or multimodal data. Conclusions: Real-time passive monitoring via wearable devices and smartphones holds promise for personalized self-management, but key gaps remain, such as a lack of longitudinal and long-term studies with data collection for 1 year or longer, studies with confirmatory parameters on an individual level, and studies with a strong correlation between parameters in individual patients to support clinical decision-making. Improvements in reporting standards are highly recommended to provide better-informed insights for clinicians. Throughout this process, there is a clear need to address various other issues, such as limited types of collected data, reliability, user adherence, and privacy concerns. Trial Registration: PROSPERO CRD42022355696; https://www.crd.york.ac.uk/PROSPERO/view/CRD42022355696


  • Open Access

    Links between self-monitoring data collected through smartphones and smartwatches and the individual disease trajectories of adult patients with depressive disorders: Study protocol of a one-year observational trial

    by Hanna Reich, Simon Schreynemackers, Rebeka Amin, Sascha Ludwig, Jil Zippelius, Johannes Leimhofer, Tobias Dunker, Elisabeth Schriewer, Angela Carell, Yvonne Weber, et al.


  • Open Access

    Distinguishing Common Parameters for Monitoring and Predicting Depression via Digital Tools. A Scoping Review (Preprint)

    by Lisa Busshart, Milica Petrovic, Rebeka Amin, Ulrich Hegerl

    BACKGROUND Digital health interventions based on self-management strategies aim to empower users’ self-reliance by utilizing self-monitoring, self-assessment and sensor-based output. The existing variety of digital devices utilizes a wide range of data sources and sensors to collect and monitor users’ output while little comparative data on parameter reliability and utility is available. OBJECTIVE This review aims to address the existing methodological and knowledge gap in understanding the efficient common parameters used among digital health interventions for depression that allow precise monitoring and prediction of the course of depression across different modes of digital intervention delivery. METHODS Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews digital databases including PubMed, Embase, Cochrane Library and Web of Science Core Collection were scoped for literature ranging from 2021 to 2024. A five-stage framework by Arksey and O’Malley (2005) was implemented to ensure systematic scoping of the literature. The quality of the retrieved studies was assessed using the Downs and Black Instrument and the Mixed Methods Appraisal Tool. RESULTS The overall five interdependent categories were defined including 1) Physical activity and Location, 2) Behavioural patterns, 3) Physiological data, 4) Sleep, and 5) Sociability and Self-reported assessments to best describe common assessment parameters across the literature. Eleven common clinical measures and self-report assessments were distinguished across defined categories as assessment combined with digital phenotyping methodology. CONCLUSIONS Synthesis of result sections of the included studies indicated that predicting depressive symptoms by combining clinical assessment and digital phenotyping is a promising approach for further improvement of digital interventions. The overall strongest associations were found in combined approaches using parameters across categories combining sensor data and self-report assessment.

  • Open Access

    Use of Mobile Sensing Data for Longitudinal Monitoring and Prediction of Depression Severity: Systematic Review (Preprint)

    by Rebeka Amin, Simon Schreynemackers, Hannah Oppenheimer, Milica Petrovic, Ulrich Hegerl, Hanna Reich

    BACKGROUND Depression is highly recurrent and heterogeneous. The unobtrusive, continuous collection of mobile sensing data via smartphones and wearable devices offers a promising approach to monitor and predict individual depression trajectories, distinguish illness states, and anticipate changes in symptom severity. OBJECTIVE This systematic review evaluates whether objective data from wearable devices and smartphones can (1) monitor and distinguish different states of depression, (2) predict changes in symptom severity, and (3) identify clinically relevant objective features for tracking and forecasting depression within diagnosed individuals. METHODS We searched PubMed and Web of Science databases for English-language studies (published 2012-2022) that used smartphone or wearable device data, included participants aged ≥14 years with a depression diagnosis, and collected continuous data for at least 12 weeks. RESULTS Out of 12,997 peer-reviewed articles, 9 original studies met the inclusion criteria, with sample sizes ranging from 45 to 2200 and durations of 12-52 weeks. Of the 9 studies, 3 used smartphone data, 1 used wearable device data, and 5 used both data types. Commonly collected variables were step count, distance moved, smartphone usage, call logs, sleep, heart rate, light exposure, and speech patterns. One study (11%) successfully differentiated between depressive states (worsening, relapse, or recovery). Six studies (67%) showed that mobile sensing data could predict depressive episodes or symptom severity. Four studies reported the predictive accuracy for depression using mobile sensing data from smartphones and wearable devices, ranging from 81% to 91%. Higher accuracy was achieved with personalized models or multimodal data. CONCLUSIONS Real-time passive monitoring via wearable devices and smartphones holds promise for personalized self-management, but key gaps remain, such as a lack of longitudinal and long-term studies with data collection for 1 year or longer, studies with confirmatory parameters on an individual level, and studies with a strong correlation between parameters in individual patients to support clinical decision-making. Improvements in reporting standards are highly recommended to provide better-informed insights for clinicians. Throughout this process, there is a clear need to address various other issues, such as limited types of collected data, reliability, user adherence, and privacy concerns. CLINICALTRIAL PROSPERO CRD42022355696; https://www.crd.york.ac.uk/PROSPERO/view/CRD42022355696


  • Open Access

    The structure of the quality of clinical practice guidelines with the items and overall assessment in AGREE II: a regression analysis

    by Yosuke Hatakeyama, Kanako Seto, Rebeka Amin, Takefumi Kitazawa, Shigeru Fujita, Kunichika Matsumoto, Tomonori Hasegawa

    Background: The Appraisal of Guidelines for Research & Evaluation (AGREE) II has been widely used to evaluate the quality of clinical practice guidelines (CPGs). While the relationship between the overall assessment of CPGs and scores of six domains were reported in previous studies, the relationship between items constituting these domains and the overall assessment has not been analyzed. This study aims to investigate the relationship between the score of each item and the overall assessment and identify items that could influence the overall assessment. Methods: All Japanese CPGs developed using the evidence-based medicine method and published from 2011 to 2015 were used. They were independently evaluated by three appraisers using AGREE II. The evaluation results were analyzed using regression analysis to evaluate the influence of 6 domains and 23 items on the overall assessment. Results: A total of 206 CPGs were obtained. All domains and all items except one were significantly correlated to the overall assessment. Regression analysis revealed that Domain 3 (Rigour of Development), Domain 4 (Clarity of Presentation), Domain 5 (Applicability), and Domain 6 (Editorial Independence) had influence on the overall assessment. Additionally, four items of AGREE II, clear selection of evidence (Item 8), specific/unambiguous recommendations (Item 15), advice/tools for implementing recommendations (Item 19), and conflicts of interest (Item 22), significantly influenced the overall assessment and explained 72.1% of the variance. Conclusions: These four items may highlight the areas for improvement in developing CPGs.